Publication Plan 2017
|
|
|
- Ralph Copeland
- 5 years ago
- Views:
Transcription
1 Publication Plan 2017 A passion for turning high quality, independent research insights into actionable commercial intelligence. Why Spherix Global Insights? Our independent reports are designed, developed, and fielded by Spherix. We aspire to be the intelligence provider of choice in the select therapy areas we cover and therefore we invest in our client relationships as long-term partnerships. Our intelligence teams have extensive experience in market research, data analysis, pharma brand management, and strategic marketing. We understand the business context of the research because our leadership has been in the decision-maker s seat before and understands the challenges and missed opportunities caused by data you can t be truly confident in. We are hyper-focused on just three specialty areas because we believe in mastery. This ensures we bring a deep understanding of both the clinical aspects and market dynamics for the diseases we work with. Working with our KOL advisory boards in each of our focus areas, we keep our finger on the pulse of the key clinical and commercial market issues and drivers. Our experts also provide input and interpretation of the findings to finely tune the final reports. Our research is conducted in collaboration with our proprietary networks of engaged physicians, ancillary healthcare professionals and patients. By cultivating our own proprietary networks, we can control the quality of the respondents and ensure that you are getting insights from a group representative of your customer base. At Spherix, the report is only part of the deliverable. Our insights are customized to your business needs and we thrive on delivering not just data, but context. Invest In Intelligence That Delivers. For more information about Spherix Global Insights and our services, contact us at info@spherixglobalinsights.com or call (484) Visit our website:
2 Nephrology Our focus will be on bone and mineral metabolism, renal anemia, hyperkalemia, diabetic nephropathy, chronic kidney disease and dialysis. Survey of highly dynamic markets, tracking brand usage, awareness, industry contacts and evolving perceptions. RealTime Dynamix: Bone and Mineral US 2017 (quarterly: Mar, Jun, Sep, Dec) RealTime Dynamix: Hyperkalemia Card US 2017 (quarterly: Feb, May, Aug, Nov) RealTime Dynamix: Hyperkalemia Neph US 2017 (quarterly: Feb, May, Aug, Nov) RealTime Dynamix: Renal Anemia US 2017 (quarterly: Mar, Jun, Sep, Dec) RealTime Dynamix: Renal Dietitians US 2017 (quarterly: Mar, Jun, Sep, Dec) RealTime Dynamix: Bone and Mineral EU (annual: Sep) RealTime Dynamix: Hyperkalemia Neph EU (annual: Sep) RealTime Dynamix: Nurse Practitioners /PA US 2017 (annual: Aug) RealTime Dynamix: Renal Anemia EU (annual: Sep) In-depth analysis of a robust sample of patient journeys detailing the realities of current RealWorld Dynamix: Chronic Kidney Disease US 2017 (Dec) RealWorld Dynamix: Dialysis US 2017 (Jun) RealWorld Dynamix: Hyperkalemia US 2017 (Nov) A forward looking report to anticipate how emerging treatments will influence future Market Dynamix: Diabetic Kidney Disease 2017 (Aug) Market Dynamix: Renal Anemia 2017 (Sep)
3 Immunology Targeted biologics, the recent emergence of innovative new oral therapies and the imminent arrival of biosimilars will continue to fuel monumental shifts in the way patients with auto-immune disorders are managed. More than ever, for both existing brands & pipeline products, future success will require a deep understanding of this complex and rapidly evolving landscape. Survey of highly dynamic markets, tracking brand usage, awareness, industry contacts and evolving perceptions. RealTime Dynamix: Atopic Dermatitis US 2017 (quarterly: Mar, Jun, Sep, Dec) RealTime Dynamix: IBD US 2017 (quarterly: Mar, May, Aug, Nov) RealTime Dynamix: Psoriatic Arthritis US 2017 (quarterly: Mar, Aug, Oct, Dec) RealTime Dynamix: Psoriasis US 2017 (quarterly: Mar, Jun, Sep, Dec) RealTime Dynamix: Rheumatoid Arthritis US 2017 (quarterly: Mar, Aug, Oct, Dec) RealTime Dynamix: Ankylosing Spondylitis & Non-Radiographic Axial Spondyloarthritis US 2017 (bi-annual: Jun, Dec) RealTime Dynamix: Psoriatic Arthritis EU 2017 (annual: Jun) RealTime Dynamix: Rheumatoid Arthritis EU 2017 (bi-annual: May, Nov) In-depth analysis of a robust sample of patient journeys detailing the realities of current RealWorld Dynamix: Biologic Switching in IBD US 2017 (Jun) RealWorld Dynamix: Biologic/Otezla Switching in Psoriatic Arthritis US 2017 (May) RealWorld Dynamix: Biologic/Otezla Switching in Psoriasis US 2017 (Nov) RealWorld Dynamix: Biologic/JAK Switching in Rheumatoid Arthritis US 2017 (Oct) RealWorld Dynamix: Biologic/JAK Switching in Rheumatoid Arthritis EU 2017 (Nov)
4 Neurology The multiple sclerosis (MS) market is more dynamic than ever with more than 10 disease-modifying therapies (DMTs) currently available. In addition, evolving attitudes around safety issues and heavy promotion aimed at clinicians and patients has made the competitive environment increasingly complex. This is why Spherix has an intense focus on the Multiple Sclerosis market. Survey of highly dynamic markets, tracking brand usage, awareness, industry contacts and evolving perceptions. RealTime Dynamix: Multiple Sclerosis US 2017 (quarterly: Mar, Jun, Sep, Dec) RealTime Dynamix: Multiple Sclerosis EU 2017 (annual: Oct) RealTime Dynamix: Multiple Sclerosis Advanced Practice Providers US 2017 (annual: Sep) In-depth analysis of a robust sample of patient journeys detailing the realities of current RealWorld Dynamix: DMT New Starts in Multiple Sclerosis US 2017 (Jan) RealWorld Dynamix: DMT Switching in Multiple Sclerosis US 2017 (Apr) RealWorld Dynamix: The Use of Monoclonal Antibody DMTs in Multiple Sclerosis US 2017 (Nov)
5 2016 Publications Nephrology RealTime Dynamix: Bone and Mineral US 2016 (monthly) RealTime Dynamix: Renal Anemia US 2016 (monthly) RealTime Dynamix: Hyperkalemia US 2016 (monthly) RealTime Dynamix: Hyperkalemia (Cardiology) US 2016 (quarterly) RealTime Dynamix: Nurse Practitioners /PA US 2016 (annually) RealTime Dynamix: Renal Dietitians US 2016 (bi-annually) RealWorld Dynamix: Hyperkalemia US 2016 RealWorld Dynamix: Chronic Kidney Disease US 2016 Market Dynamix: Future Treatment of Renal Anemia 2016 Market Dynamix: Diabetic Nephropathy 2016 Neurology RealTime Dynamix: Multiple Sclerosis US 2016 RealWorld Dynamix: DMT Switching in MS (US) RealWorld Dynamix: DMT Switching in MS (EU5)
6 2016 Publications Immunology RealTime Dynamix: Rheumatoid Arthritis 2016 RealTime Dynamix: Psoriatic Arthritis 2016 RealTime Dynamix: Psoriasis 2016 (Q2, Q3, Q4) RealTime Dynamix: Ulcerative Colitis 2016 (Q3, Q4) RealTime Dynamix: Crohn s Disease 2016 (Q3, Q4) RealWorld Dynamix: Biologic Switching in Rheumatoid Arthritis 2016 RealWorld Dynamix: Biologic Switching in Psoriatic Arthritis 2016 RealWorld Dynamix: Biologic and Otezla use in Psoriasis 2016 RealWorld Dynamix: Biologic Switching in IBD (UC/CD) 2016 Market Dynamix: Atopic Dermatitis Pulmonology RealWorld Dynamix: Idiopathic Pulmonary Fibrosis US 2016
7 2015 Publications Nephrology RealTime Dynamix: Nephrology Annual Compendium RealTime Dynamix: Bone and Mineral 2015 Annual Compendium RealTime Dynamix: Renal Anemia 2015 Annual Compendium RealTime Dynamix: Hyperkalemia 2015 Annual Compendium RealTime Dynamix: Renal Dietitians 2015 RealWorld Dynamix: Hyperkalemia US 2015 Caseload Dynamix: Nephrology US 2015 Market Dynamix: Hyperkalemia US 2015 Market Dynamix: Hyperkalemia EU 2015 Immunology RealTime Dynamix: Rheumatoid Arthritis Annual Compendium RealTime Dynamix: Psoriatic Arthritis Annual Compendium Neurology RealTime Dynamix: Multiple Sclerosis - US Annual Compendium Pulmonology Market Dynamix: Idiopathic Pulmonary Fibrosis 2015
Jefferies Healthcare Conference June 6, 2018
Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development
Pfizer Independent Grants for Learning & Change Track 2- Annual Meetings: Submission Deadlines, Areas of Interest & Educational Goals
In order to submit a request for general meeting support through Track 2- Annual Meetings the answer to the following questions must be Yes : Does the activity align with Pfizer s areas of interest? (listed
STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.
STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS. Acknowledgements This project was fully funded by Center For Disease Control
Jefferies Healthcare Conference. June 6, 2018
Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements and Non-GAAP Financial Information Some statements in this presentation may be forward-looking statements for purposes of the Private
Credit Suisse 27 th Annual Healthcare Conference
CHANGING THE COURSE OF HUMAN HEALTH THROUGH BOLD PURSUITS IN SCIENCE Credit Suisse 27 th Annual Healthcare Conference November 14, 2018 Forward-Looking Statements and Adjusted Financial Information This
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016 BioPortfolio has been marketing business
Sleep Market Panel. Results for June 2015
Sleep Market Panel Results for June 2015 Notes: o This is a monthly trending report of panel member data along with additional analysis by: Sleep labs affiliated with Hospitals vs. Independent Labs o Hospital
Successful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome
Successful Falls Prevention in Aged Persons Mental Health Reducing the risk and decreasing severity of outcome Vahitha Koshy Seema Dua Elda Kimberlee Introduction Unit 3- Acute Aged Mental Health inpatient
Primary Care Commission Study Visit. 26 March 2015
Primary Care Commission Study Visit 26 March 2015 1 Agenda 1. How we got to where we are? 2. Suffolk GP Federation 3. North East Essex diabetes service 4. Working at scale issues and challenges 2 1. How
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH
1 Monitoring Protocol for Clozapine-induced Myocarditis 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives
Case Study: Physician and Patient-Facing Medical Education APPs. Sandeep Pulim, MD Chief Medical Information Officer
Case Study: Physician and Patient-Facing Medical Education APPs Sandeep Pulim, MD Chief Medical Information Officer Quality IME Collaborating for Patient Care Commercial Supporter Medical Education Provider
Primary Results Citation 2
Table S1. Adalimumab clinical trials 1 ClinicalTrials.gov Rheumatoid Arthritis 3 NCT00195663 Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study. A multicenter, randomized, double-blind clinical
REFERENCE CODE GDHC504DFR PUBLICAT ION DATE DECEMBER 2014 SARILUMAB (RHEUMATOID ARTHRITIS) FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC504DFR PUBLICAT ION DATE DECEMBER 2014 SARILUMAB (RHEUMATOID ARTHRITIS) Executive Summary The table below presents the key metrics for Sarilumab in the 10MM Rheumatoid Arthritis (RA)
Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization. Presenters: John Atkinson & Elizabeth Harvey
Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization Presenters: John Atkinson & Elizabeth Harvey WHAT IS THE FIRST WEEK CHALLENGE? Monthly campaign Register online or by
ACTEMRA/ROACTEMRA (TOCILIZUMAB) (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC498DFR PUBLICATION DATE DECEM BER 2014 ACTEMRA/ROACTEMRA (TOCILIZUMAB) (RHEUMATOID ARTHRITIS) - Executive Summary The table below provides the key metrics for Actemra/RoActemra (tocilizumab)
FY 2014 ANNUAL MANAGEMENT REPORT
THE DEFENSE INTELLIGENCE AGENCY LEADER EVALUATION of DEVELOPMENT and INVESTMENT DIALED IN FY 2014 ANNUAL MANAGEMENT REPORT A report designed to aid in making informed evidence-based decisions when recommending
REFERENCE CODE GDHC496DFR PUBLICAT ION DATE DECEMBER 2014 CIMZIA (CERTOLIZUMAB PEGOL) (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC496DFR PUBLICAT ION DATE DECEMBER 2014 CIMZIA (CERTOLIZUMAB PEGOL) (RHEUMATOID ARTHRITIS) - Executive Summary The table below provides the key metrics for Cimzia (certolizumab pegol)
REFERENCE CODE GDHC509DFR PUBLICAT ION DATE DECEMBER 2014 MAVRILIMUMAB (RHEUMATOID ARTHRITIS) FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC509DFR PUBLICAT ION DATE DECEMBER 2014 MAVRILIMUMAB (RHEUMATOID ARTHRITIS) Executive Summary The table below presents the key metrics for Mavrilimumab in the 10MM Rheumatoid Arthritis
RTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
REFERENCE CODE GDHC501DFR PUBLICAT ION DATE DECEMBER 2014 XELJANZ (TOFACITINIB) (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC501DFR PUBLICAT ION DATE DECEMBER 2014 XELJANZ (TOFACITINIB) (RHEUMATOID ARTHRITIS) - Executive Summary The table below provides the key metrics for Xeljanz (tofacitinib) in the 10MM
WCO Strategic Initiatives for Trade Facilitation
International Seminar on Trade Facilitation in North East Asia 13 December 2016 Incheon, Republic of Korea WCO Strategic Initiatives for Trade Facilitation Ms. Alpha WONG World Customs Organization (WCO)
Rural Health Initiative
Rural Health Initiative 1 Our Vision For Rural Health To facilitate best in class health care in rural areas and reduce rural health care in Idaho as a disparity. To facilitate equity in health in rural
FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS
AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS FIRM CAPACITY - First Monday of July 01.06.2019* 01.07.2019 07:00 01.10.2019 04:00 01.10.2020 04:00 2019/2020 01.10.2020 04:00 01.10.2021
Media Kit. September 2017
Media Kit September 2017 About Pear Pear Therapeutics is the leader in FDA-cleared Prescription Digital Therapeutics. The company s approach is to integrate clinically-validated software applications with
Achieving Performance Excellence Using Emotional Intelligence
Achieving Performance Excellence Using Emotional Intelligence Page 1 of 9 Why Attend The performance of individuals is important as it determines the individuals success and the survival of the organization.
How a Signs of Safety approach is changing practice in Norfolk. Andrea Brown Principal Social Worker Community Care- Live Tuesday 10 th May 2016
How a Signs of Safety approach is changing practice in Norfolk Andrea Brown Principal Social Worker Community Care- Live Tuesday 10 th May 2016 The Norfolk Context 2014 OFSTED What did we need to do? Address
Disclosures. Learning Objectives. Improving HPV Immunization Rates in a Large Pediatric Practice: Implementing Effective Quality Improvement
Improving HPV Immunization Rates in a Large Pediatric Practice: Implementing Effective Quality Improvement Alix Casler, M.D., F.A.A.P. Medical Director of Pediatrics, Orlando Health Physician Associates
In all of these roles, I've used healthcare data to drive strategy for the life sciences industry.
Intro: When you take a magnifying glass and look at a picture, you see that it's made up of thousands of dots and when you pull back, those dots become the details that create the picture. There's real
Alignment Strategies at the JPS Health Network
Improving the Patient Experience Alignment Strategies at the JPS Health Network JPS HEALTH NETWORK 537 bed hospital, Level 1 Trauma Center Tarrant County s Safety Net Hospital 15 primary care clinics 20
East London Community Kidney Service
East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen Rainey April 2017 Haemodialysis/million population What is the Problem? Fast rising ESRD rates in East London
Q1 Results 2018 Webcast presentation 26 April 2018
Q1 Results 2018 Webcast presentation 26 April 2018 Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline,
REFERENCE CODE GDHC502DFR PUBLICAT ION DATE DECEMBER 2014 IGURATIMOD/T-614 (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC502DFR PUBLICAT ION DATE DECEMBER 2014 IGURATIMOD/T-614 (RHEUMATOID ARTHRITIS) - Executive Summary The table below provides the key metrics for Iguratimod/T-614 in the 10MM (US, France,
Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica
Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action
Pfizer Independent Grants for Learning & Change Track 2- Annual Meetings: Submission Deadlines, Areas of Interest & Educational Goals
In order to submit a request for general meeting support through Track 2- Annual Meetings the answer to the following questions must be Yes : Does the activity align with Pfizer s areas of interest? (listed
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
Healthcare for the Emerging Middle Class
Healthcare for the Emerging Middle Class Type 2 diabetes care design in India May 2014 1 When looking for healthcare opportunities in emerging markets, project teams on the ground are less influenced by
Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)
14 July 2015 Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) PHARMAC is seeking feedback on a proposal relating to the funding of the TNF-inhibitor medicines
An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care
An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care John G. Abbott Deputy Minister, Department of Health and
UCB Inspired by patients. Driven by science.
UCB Inspired by patients. Driven by science. 3 months interim Report Brussels, 24 April 2017 Carolin, living with epilepsy and axial spondyloarthritis Disclaimer and safe harbor Forward-looking statements
TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY
TRANSFORMING STROKE CARE IN THE CAPITAL: THE LONDON STROKE STRATEGY LUCY GROTHIER Director South London Cardiac and Stroke Network lucy.grothier@slcsn.nhs.uk 27 th May 2011 Gaps in London stroke care GAPS
Magellan Rx. A smarter approach to pharmacy benefits management
Magellan Rx A smarter approach to pharmacy benefits management Presented by: Cheri Caruso, VP of Sales, Magellan Rx Management Bryce Canfield, VP, Client Development, GoodRx A unique vision of care We
SEO CASE STUDY KIDS KLUB DENTISTRY
SEO CASE STUDY KIDS KLUB DENTISTRY Our mission is to provide state-of-theart website design and web marketing solutions at an affordable price to the dental community, while maintaining customer service
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations
Analysis of Meter Reading Validation Tolerances proposed by Project Nexus
Analysis of Meter Reading Validation Tolerances proposed by Project Nexus January 2014 Description of analysis Aim of analysis: To assess the impact of the meter read validation tolerances that have been
BDS ANALYTICS Top Ten Cannabis Market Trends for 2019
BDS ANALYTICS Top Ten Cannabis Market Trends for 2019 Presented by: Roy Bingham CEO and Co-Founder roy@bdsanalytics.com Jessica Lukas VP, Consumer Insights Jessica@bdsanalytics.com 2018 PREDICTIONS https://bdsanalytics.com/bds-analytics-top-10-cannabis-market-trends-2018/
Probiotics Market Size, Share, Analysis, Growth, Trends, Outlook and Forecasts to 2024 Hexa Research
Probiotics Market Size, Share, Analysis, Growth, Trends, Outlook and Forecasts to Hexa Research The global probiotics market size was valued at USD 38.32 billion in 2016. Increasing prevalence of Irritable
Short Range Outlook for Steel Demand Autumn OECD Steel Committee, Paris, 10 December Short Range Outlook overview
Short Range Outlook for Steel Demand Autumn 29 OECD Steel Committee, Paris, 1 December 29 Content Short Range Outlook overview Background of the Forecast Regional overviews Conclusion 2 1 Short Range Outlook
ABBVIE VENTURES VISION. Drive strategic returns to AbbVie as a key constituent of overall corporate strategy
ABBVIE VENTURES ABBVIE VENTURES VISION Drive strategic returns to AbbVie as a key constituent of overall corporate strategy Early access to external innovation with a long-term horizon to generate meaningful
Championing Information Management to Improve System Performance and Patient Care
Championing Information Management to Improve System Performance and Patient Care Michael Sherar President and CEO Cancer Care Ontario December 1, 2011 Overview Cancer Care Ontario Elements of Cancer Care
Atrial Fibrillation - Pipeline Review, H1 2017
Report Information More information from: https://www.wiseguyreports.com/reports/1095866-atrial-fibrillation-pipeline-review-h1-2017 Atrial Fibrillation - Pipeline Review, H1 2017 Report / Search Code:
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research reports
SUPPLIER/MANUFACTURER PERFORMANCE REPORT
80/30 MOO 8 PHAHOLYOTHIN RD., T.KUKHOT, A.LUMLOOKKAR, PATHUMTHANI 30, THAILAND TEL : (66-) 9958 9, 995330 FAX : (66-) SUPPLIER/MANUFACTURER PERFORMANCE REPORT 80/30 MOO 8 PHAHOLYOTHIN RD., T.KUKHOT, A.LUMLOOKKAR,
Provider Service Model. Collaborating for Success Jodi Stockslager, Sr. Provider Advocate, Provider Relations
Provider Service Model Collaborating for Success Jodi Stockslager, Sr. Provider Advocate, Provider Relations Agenda Welcome / Introductions UnitedHealthcare overview Member ID Cards Products and networks
South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free
Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars
Education around PML risk and monitoring at NHNN Queen Square MS Centre
Audit MS Masterclass, Sheffield, 31 st March 2017 Education around PML risk and monitoring at NHNN Queen Square MS Centre UCL Institute of Neurology Queen Square Multiple Sclerosis Centre National Hospital
The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement
The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement Georgia Vascular Society Adam W. Beck, MD, FACS September 9, 2017 Disclosures No relevant
Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016
Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been
Building Capacity for Smoking Cessation Treatment Within Primary Care Teams
Building Capacity for Smoking Cessation Treatment Within Primary Care Teams Justine Mascarenhas, MSc and Janine Fitzpatrick, MCogSc Investigators: Dr. Peter Selby and Dr. Laurie Zawertailo STOP Program,
HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE
HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE Site C Youth clinic HIV care pathway DAY 1 Test HIV + PIMA point of care CD4 count in in 3-5 days initiation + in session 3 session 4 1 month Youth Club
Cowen Healthcare Conference
Cowen Healthcare Conference Shire plc March 9, 2010 Michael Cola President, Specialty Pharmaceuticals Our purpose We enable people with life-altering conditions to lead better lives 1 THE SAFE HARBOR STATEMENT
Transforming health through IT
@himsseurope HIMSS Europe 02 HIMSS Europe www.himss.eu The Leading Health IT Knowledge Organisation HIMSS Europe is a voice, advisor and thought leader of transformation through health IT. As an independent
Breakthroughs in Quality: Improving Patient Care in Wisconsin
Breakthroughs in Quality: Improving Patient Care in Wisconsin Wisconsin Collaborative for Healthcare Quality Cindy Schlough Director of Strategic Partnerships Wisconsin Collaborative for Healthcare Quality
FFT and Patient Insight for Improvement. Marie Allen Head of Service User and Carer Experience
FFT and Patient Insight for Improvement Marie Allen Head of Service User and Carer Experience 142 Community Integrated Health and Adult Social Care Teams: District nurses Allied Health Professionals Dental
City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)
City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS) Vancouver Vancouver Fire Rescue Services Opioid Crisis Background Crisis Overview April
Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station
Click here for the corrections made < Reference > December 3, 212 Tokyo Electric Power Company Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station * As of
We empower women toward
2018 Workshop Series We empower women toward economic independence by providing a network of support, professional attire, and programs to help them thrive in work and in life. Our workshops and programs
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research "Type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding
U.S. Flue-Cured Tobacco Situation & Outlook February 6, 2015
U.S. Flue-Cured Tobacco Situation & Outlook February 6, 2015 Dr. Blake Brown Hugh C. Kiger Professor Agriculture & Resource Economics College of Agriculture & Life Sciences How much are contracted pounds
Integrated VL/EID& TB Data Review Meeting 23/3/2018 PIATO
Integrated VL/EID& TB Data Review Meeting 23/3/2018 PIATO OBJECTIVES 1.To review progress of national viral load monitoring, EID &TB 2. To share experiences and implementing challenges. 3. To forge a way
AHP Musculoskeletal Service Redesign. Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran
AHP Musculoskeletal Service Redesign Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran Local Drivers Routine referral practice Via acute care, duplication Long waiting times
MArch The 2014 Drug Trend Report Highlights
MArch 2015 The 2014 Drug Report Highlights Highest Increase in U.S. Drug Spend Over Past Decade In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers
Cowen Healthcare Conference March 12, 2018
Cowen Healthcare Conference March 12, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development
PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research
McLean ebasis plus TM
McLean ebasis plus TM Sample Hospital (0000) Report For Qtr HBIPS Core Measures McLean Hospital 115 Mill Street Belmont, MA 02478 1 2012 Department of Mental Health Services Evaluation Tel: 617-855-3797
Presentation to 2019 JP Morgan Healthcare Conference
For immediate release 10 January 2019 Presentation to 2019 JP Morgan Healthcare Conference Please find attached CSL Limited s presentation at the 2019 JP Morgan Healthcare Conference. For further information,
Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:
Surveillance: Report: Clostridium difficile (C. difficile) and Staphylococcus aureus ( and ) Bi-annual Report Time period: 1 st April to 30 th September 2016 Health Board: Wales Content: Issued by: Pg
Charité Research Organisation Our Concept
Charité Research Organisation Our Concept Charité Research Organisation Charité owned operationally independent scientifically driven Experience Conducted more than 300 First Time in Human, Phase 1 and
U.S. Medical Cannabis Market Share, Size, Analysis, Growth, Regional Outlook, Trends and Forecasts to 2024 Hexa Research
U.S. Medical Cannabis Market Share, Size, Analysis, Growth, Regional Outlook, Trends and Forecasts to 2024 Hexa Research "U.S. Medical Cannabis Market Size Worth USD 19.48 Billion By 2024." 27 December
Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center
Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center Kaela Momtselidze Health Systems Manager Primary Care Systems American Cancer Society Sheri Frank Director of Corporate
IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program
IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE A Clinical Quality Improvement Program Today: National completion rates for OTP s hover between 11 14% Retention
th Medical Group Report Card
2015 366th Medical Group Report Card What is Quality Healthcare? Quality healthcare can be defined as the extent to which patients get the care they need in a manner that most effectively protects or restores
Lung Cancer MCN Work Plan 2017/18
Lung Cancer MCN Work Plan /18 Objective Deliverables / Outcomes Lead 1. Manage the development/review of Lung Cancer Management Guidelines Regional Management Guidelines circulated for implementation.
Institute of Quality Leadership AMGA
Institute of Quality Leadership AMGA Ajay Sahajpal, MD Director Abdominal Transplant and Hepatobiliary Program Bradley Kruger, VP Operations ASLMC Laura Spurr, Director Clinical Transformation and Operations
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder- Addison Complex) - Pipeline Review, H2 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2016 Adrenoleukodystrophy
Cumbria Diabetes Dr Cathy Hay Clinical Director Cumbria Diabetes Cumbria Partnership NHS Foundation Trust
Cumbria Diabetes 2011 Dr Cathy Hay Clinical Director Cumbria Diabetes Cumbria Partnership NHS Foundation Trust Forecasted Numbers for Diabetes in Cumbria 2005 2025 (Source: PBS Prevalence Model) 45,000
Improving Opioid Agonist Therapies with System Change
Improving Opioid Agonist Therapies with System Change DENNIS MCCARTY OHSU- PSU SCHOOL OF PUBLIC HEALTH OREGON HEALTH & SCIENCE UNIVERSITY PORTLAND, OR 97239 BOOST LAUNCH VANCOUVER, BC SEPTEMBER 15, 2017
Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X
Primary Prevention Breast Cancer Prevention Member: Mammography reminder letters to female members ages 51.5-74 who are overdue to get a mammogram Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Providers:
Drug Name (specify drug) Quantity Frequency Strength
Prior Authorization Form GEHA FEDERAL - STANDARD OPTION Autoimmune Conditions (FA-PA) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
21 st Annual Needham Growth Conference
21 st Annual Needham Growth Conference Title January 15, 2019 Bonnie Anderson Chairman and Chief Executive Officer Forward-Looking Statements This presentation contains forward-looking statements, within
Attracting Talent & Driving Growth in Wisconsin
Attracting Talent & Driving Growth in Wisconsin v 2 nd Annual Future Wisconsin Economic Summit Kevin Conroy, Chairman & CEO December 9, 2015 WMC Foundation: Second Annual Future Wisconsin Economic Summit
Aesthetic Laser - Medical Devices Pipeline Assessment, 2016
Aesthetic Laser - Medical Devices Pipeline Assessment, 2016 Aesthetic Laser - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been marketing business and market research reports from selected
Executive Women s Breakfast Patient Advocacy Real Trust, Real Partnerships for Real Innovation
Executive Women s Breakfast Patient Advocacy Real Trust, Real Partnerships for Real Innovation June 15, 2010, Merck & Co. Inc. This well-attended Executive Women s Breakfast (EWB) featured an executive
NCHIP A Learning & Implementation Collaborative Maryland State Conference May 8, 2013
NCHIP A Learning & Implementation Collaborative Maryland State Conference May 8, 2013 Using an Improvement Model for Implementation NCHIP s evolving structure Improvement model ingredients Implementation
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business
Measure Up/Pressure Down Medical Group Success
Measure Up/Pressure Down Medical Group Success Deborah A. Molina, MPA, MBA Manager, Quality Jamie L. Reedy, MD, MPH Medical Director, Population Health Laura Balsamini, Pharm D, BCPS Director, Pharmacy
One Palliative Care Annual Report
One 203 Palliative Care Annual Report One In 202, ASCO released a provisional clinical opinion stating that concurrent palliative care should be considered early in the course of advanced or metastatic
Florida s New Economic Reality: The State of the State
Florida s New Economic Reality: The State of the State FLORIDA PHILANTHROPIC NETWORK Dr. Gary Jackson Director, Regional Economic Research Institute Florida Gulf Coast University February 11, 2010 www.fgcu.edu/cob0/reri